Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 OCT 19 ... (NASDAQ: CRXX) announced that its abstract entitled, "CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA ...
2009 NOV 2 ... without associated side effects. Synavive contains the cardiovascular agent dipyridamole and a very low dose of the glucocorticoid prednisolone and is being developed as a ...
2009 NOV 16 ... gadolinium-enhancement with mild hypokinesis in the mid to basal inferolateral segments. Dipyridamole T1-201 single photon emission computed tomography 6 months later demonstrated ...
2009 NOV 2 ... was associated with less severe stroke upon presentation. A similar trend was seen with dipyridamole and ticlopidine, but did not reach statistical significance. Pre treatment with ASA and ...
2009 AUG 24 ... 10 years) with reversible myocardial perfusion defects on (TI)-T-201-SPECT images during dipyridamole-stimulated hyperemia were recruited for study purpose." "Within 5 days of ...
2009 SEP 21 ... Blockade of A(2A) receptors with ZM 241385, inhibition of adenosine transport with dipyridamole, and inhibition of ecto-5'-nucleotidase with concanavalin A, all attenuated release ...
2009 OCT 5 ... a study from Turku, Finland, "Myocardial blood flow was measured at baseline and during dipyridamole-induced hyperaemia by PET. Peripheral artery endothelial function was examined by ...
2009 SEP 28 ... proteins in mural granulosa cells and cumulus-oocyte complexes. PDE8 inhibition using dipyridamole in a dose-dependent manner increased cAMP levels in the cumulus-oocyte complexes and ...
2009 NOV 23 ... all had undergone standard transthoracic Doppler-echo study, coronary angiography and dipyridamole stress transoesophageal echocardiography as CFR measurement. During a mean follow-up of ...
2009 NOV 2 ... recent research published in the journal Thrombosis and Haemostasis, "Extended release dipyridamole (ERD) is widely used in patients after ischaemic stroke; however, the ability of this ...
2009 AUG 24 ... New research, 'Comparison of the prognostic value of dipyridamole and dobutamine myocardial perfusion scintigraphy in hemodialysis patients,' is the ...
2009 NOV 23 ... of CAD were studied. All patients underwent Tc-99m-MIBI myocardial perfusion scan using dipyridamole as pharmacological stress. All patients were followed up by reviewing patients file in ...
2009 SEP 28 ... the cream in the same way they apply sunscreen products. The mimicking cream contained dipyridamole, which is fluorescent under Wood's light (WL). Cream distribution on skin and applied ...
2009 NOV 1 ... 1B1, 1B3, 2B1, 3A1 and 4A1 was assessed by PCR. Inhibitors of P-gp (XR9576, GF120918, dipyridamole) and MRP (MK571, frusemide, dipyridamole), and SLCO ...
2009 NOV 16 ... a single center in Turin, Italy," researchers in Turin, Italy report. "A dipyridamole-stress sestamibi myocardial scintiscan (DMS) performed in 302/558 (54.1%) cases was ...
2009 SEP 14 ... can compromise the activity of antifolates." "The cardiovascular drug dipyridamole inhibits nucleoside transport and enhances antifolate cytotoxicity in vitro, but its ...
2009 SEP 28 ... coronary artery disease and negative stress echo by wall motion criteria. All underwent dipyridamole (up to 0.84 mg/kg over 6 minutes) stress echo with CFR evaluation of either LAD or RCA ...
2009 SEP 21 ... was observed and this was also reversible with the addition of tariquidar. In PBMCs, dipyridamole (6.9 +/-1.3, p<0.01, 95% CI for the difference=-1.16, -0.30, (n=8) significantly ...
